EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Cucurbitacin I in Colon Adenocarcinoma Is Mediated by Modulation of SDHA Expression

Danni Zhao, Xunzhi Zhang, Wenke Xiao, Yue Lin, Zhixiang Wu, Xinyu Tang, Qian Cheng, Pengmian Feng, Wei Chen

Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)

DOI: 10.1111/jcmm.71231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 09.06.2026. Verfasst von Danni Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms, Gene Expression Regulation, Neoplastic, Triterpenes. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan Provience.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is a prevalent malignancy, with colon adenocarcinoma (COAD) representing its most common histological subtype. Although most stage I patients remain disease‐free after treatment, a subset rapidly progresses to advanced disease with markedly reduced survival. Therefore, identifying early molecular warning signals in stage I patients is essential for timely intervention. In this study, integrated datasets from The Cancer Genome Atlas and Genotype‐Tissue Expression projects were analysed using the landscape dynamic network biomarker ( l ‐DNB) approach to identify progression biomarkers (PBs) for COAD. Twenty PBs were identified, among which succinate dehydrogenase complex flavoprotein subunit A (SDHA) was selected for further investigation. The L1000CDS 2 database was subsequently queried utilizing these identified PBs, identifying Cucurbitacin I (CuI) as a promising therapeutic component against COAD. Molecular docking and molecular dynamics simulations demonstrated stable binding between CuI and SDHA, with a binding energy of −9.44 kcal/mol and an RMSD of 2.0 ± 0.3 Å. Subsequent in vitro experiments demonstrated that CuI treatment upregulated SDHA expression and inhibited activation of the NF‐κB pathway. Collectively, these findings suggest that the identified PBs may serve as early‐warning indicators for stage I COAD patients and that CuI suppresses COAD cell proliferation, potentially through the SDHA/NF‐κB axis, highlighting its promise as a potential therapeutic candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColonic NeoplasmsGene Expression Regulation, NeoplasticTriterpenesCucurbitacinsHumansMolecular Docking SimulationMolecular Dynamics SimulationCell Line, TumorNF-kappa BBiomarkers, TumorCell ProliferationSignal Transduction

Stichwörter der Autor:innen

colon adenocarcinomacucurbitacin Ilandscape dynamic network biomarker methodologyprogression biomarkersuccinate dehydrogenase complex flavoprotein subunit A

Substanzen

TriterpenesNF-kappa BBiomarkers, TumorCucurbitacins

Autor:innen und Institutionen

  • School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Institute of Herbgenomics, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Förderung

  • Natural Science Foundation of Sichuan Provience

Zitieren

APA

Zhao, D., Zhang, X., Xiao, W., Lin, Y., Wu, Z., Tang, X., Cheng, Q., Feng, P., & Chen, W. (2026). Therapeutic Potential of Cucurbitacin I in Colon Adenocarcinoma Is Mediated by Modulation of SDHA Expression. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71231

Vancouver

Zhao D, Zhang X, Xiao W, Lin Y, Wu Z, Tang X, et al. Therapeutic Potential of Cucurbitacin I in Colon Adenocarcinoma Is Mediated by Modulation of SDHA Expression. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71231

BibTeX
@article{Zhao2026,
  author = {Zhao, Danni and Zhang, Xunzhi and Xiao, Wenke and Lin, Yue and Wu, Zhixiang and Tang, Xinyu and Cheng, Qian and Feng, Pengmian and Chen, Wei},
  title = {Therapeutic Potential of Cucurbitacin I in Colon Adenocarcinoma Is Mediated by Modulation of SDHA Expression},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/jcmm.71231}
}
Kostenlos starten →